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ABSTRACT
The World Health Organization (WHO) considers Female Sexual Dysfunctions (FSDs) to be a public health issue. 
There are a multitude of disorders such as female sexual arousal disorder, hypoactive sexual desire disorder, 
orgasmic disorder, dyspareunia, and vaginismus. FSDs are detected in 67.9% of the women in the world and 
are present in 50% of Asians, in 30-50% of Americans, and in 30% of Brazilians. Objective: To systematically 
review the literature on the different physiotherapy techniques used in the treatment of FSDs. Methods: A 
systematic search was conducted in the databases EMBASE, PEDro, and MedLine in data as recent as June 
2013, by combining words and descriptors of physical therapy treatments and female sexual dysfunctions. 
Excluded from review were articles concerning male sexual dysfunction, pilot studies, multicentric papers of 
projects, and those which were either not available in their entirety or were duplicated in another database. 
After the selection of studies was complete, the randomized clinical trials were scored on the PEDro Evaluation 
Scale. Results: Eleven articles were included, six of which went on to be qualitatively evaluated on the PEDro 
scale. The present study followed the methodological structure of PRISMA (Statement for Reporting Systematic 
Reviews and Meta-Analyses of Studies). All studies found used questionnaires to assess the effects of physical 
therapy on FSDs. A total of five different types of interventions were verified: kinesiotherapy (Kegel exercises 
and pelvic floor muscle training - PFMT), Cognitive behavioral therapy (CBT), biofeedback, electrotherapy 
(transcutaneous electrical stimulation - TENS, and therapeutic ultrasound - US), and manual therapy. The 
limitations found in this systematic review were related to the unavailability of the articles in full and the 
low methodological quality of the studies. Conclusion: All studies showed improvements in sexual function 
after physical therapy intervention. There is no consensus on any intervention with better results; however, 
kinesiotherapy using PFMT proved to be advantageous because of its easy application, low cost, easy learning 
curve, and lasting results achieved in a short period. However, there are methodological shortcomings that still 
need to be dealt with to determine the most suitable physical therapy treatment for FSDs, as well as defining 
the best dosage, the protocol to be followed, and the duration of therapy, as well as the best cost-benefit.
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INTRODUCTION
The World Health Organization (WHO) 
considers Female Sexual Dysfunctions (FSDs) 
to be a public health issue since, in the long or 
short term, they affect the psychology, social 
and domestic life, careers, and health of wom-
en and their partners.1
FSDs include multiple disorders such as 
female sexual arousal disorder, hypoactive 
sexual desire disorder, orgasmic disorder, dys-
pareunia, and vaginismus.2 These disorders 
are classified into diagnostic categories that 
include desire or libido, excitation, pain or dis-
comfort, and inhibition of orgasm.3,4 They are 
characterized as multicausal and multidimen-
sional and they combine biological, psycholog-
ical, and interpersonal factors.2
These dysfunctions are highly prevalent, 
affecting some 67.9%5,6 of the women in the 
world. As to the indices in different coun-
tries, estimates are that FSDs are present in 
30 to 50% of American women, more than 
50% of Asian women, and in 30% of Brazilian 
women.7,8,9 In specific demographics such as 
women with diabetes,10 Parkinsons,11 and who 
have suffered heart attacks,12 the numbers are 
more dramatic, namely 59%, 75%, and 50%, 
respectively.
The practice of physiotherapy in the treat-
ment of FSDs seeks to improve the mobility 
of the pelvic floor musculature and the re-
lief of pelvic and/or abdominal pain. Various 
therapies are used for this, including pelvic 
floor muscle training,9 electrotherapy,13 and 
manual therapy.14 However, in the face of this 
coverage it becomes necessary to search for 
scientific evidence on these techniques and 
methods to determine the best route to the 
reduction of these complaints.
OBJECTIVE
In order to provide the professional ther-
apist synthesized knowledge, the objective of 
this study was to perform a systematic review 
on the different therapeutic techniques used 
in the treatment of FSDs.
METHODS
Source of data and research
The plan for this review was based on the 
guidance of the “Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses” 
(PRISMA recommendations). This systematic 
review has been registered in PROSPERO un-
der Nº CRD42015017614.
Three databases were searched: EMBASE 
(EMBASE; Web site: http://www.elsevier.
com/online-tools/embase accessed on July 1, 
2013), the Physiotherapy Evidence Database 
(Pedro; Web site: www.pedro.org.au on the 
same date), and MedLine (accessed via Ovid 
[Wolters Kluwer Health, New York, New York, 
EUA] on the same date).
Research filters were used that were devel-
oped by the Scottish Intercollegiate Guidelines 
Network - http://www.sign.ac.uk/methodology/
filters.html, using a combination of words and 
descriptors of physiotherapeutic treatments 
and female sexual dysfunctions. The terms used 
in the PEDro database were Perineum or Geni-
tor Urinary in the “body part” field; Continence 
and Women’s Health in the “subdiscipline” field; 
and Clinical Trial in the “method” field. In the 
MedLine and EMBASE databases, a cross search 
was used among the descriptors on: method-
ology (Randomized controlled trial OR random 
allocation OR double blind method OR single 
blind method OR clinical trial OR randomization 
OR single blind procedure OR double blind pro-
cedure OR crossover procedure OR placebo OR 
random allocation OR prospective study), phys-
iotherapeutic treatment (Therapy OR Rehabili-
tation OR Exercise Therapy OR Exercise OR Re-
sistance Training OR Massage OR Electric Stim-
ulation Therapy OR Physical Therapy Modalities 
OR Physical Education OR Physical Training OR 
Kinesiotherapy), and female sexual dysfunction 
(sexual dysfunction, Physiological OR Dyspareu-
nia OR Vaginismus OR Vulvodynia OR Vestibulo-
dynia OR Desire disorder OR Arousal disorder OR 
Orgasmic Disorder OR Perineum OR Pelvic Floor 
OR Pelvic Floor Muscle).
Selection of studies
After the searches, two independent re-
searchers selected the potentially relevant 
studies based on their titles. They then read 
the abstracts of those studies followed by a 
full reading of the article, at which time the 
inclusion/exclusion criteria were applied. In 
case the researchers’ opinions differed in ei-
ther phase, they argued between themselves 
and, if no agreement was reached, the third 
researcher made the final decision in a con-
sensus meeting.
Inclusion criteria
Studies in the Portuguese and English lan-
guages were included that used physiother-
apeutic techniques to treat FSDs in women. 
There was no restriction of data, so original 
articles were accepted published as late as 
June of 2013.
Exclusion criteria
Studies with men were rejected, as were 
pilot studies, multicentric papers or projects, 
those not available in their entirety upon 
e-mail request of the authors, or duplicates.
Extraction of data and evaluation 
of quality
After final selection of the studies, the 
randomized clinical trials were scored on the 
PEDro Evaluation Scale accessing the web site: 
http://www.pedro.org.au/portuguese/down-
loads/pedro-scale/. Those not indexed in the 
PEDro database were evaluated by two inde-
pendent evaluators following the norms of the 
Scale; scoring differences were settled after a 
discussion of the dubious items. The PEDro 
Evaluation Scale scores from zero to ten and 
reflects the potential bias involved in the study, 
with ten as the best possible score and zero, the 
worst. The first question is not scored.
The other types of studies were not meth-
odologically evaluated, however, their results 
are presented and discussed in this review.
Synthesis of the data
The results of the included articles were 
grouped as to: evaluative method of the FSDs; 
interventions with kinesiotherapy, electro-
therapy, manual therapy, and combined thera-
py subgroups; and methodological evaluation. 
There was no meta-analysis of the results 
found due to the heterogeneity of the tech-
niques involved in the studies, by the lack of 
consensus in dealing with the different specif-
ic characteristics of the FSD.
RESULTS
Selection of studies
The database searches netted 1,525 arti-
cles. Of those, 28 met the inclusion criteria, 
however, 11 were excluded following an anal-
ysis of their abstracts, and 6 more following an 
analysis of the full text. All in all, 11 articles 
were selected and 6 went on to be evaluated 
on the PEDro scale (Figure 1).
Evaluation of the Methodological 
Quality
The methodological evaluation scores ac-
cording to the PEDro scale are described in 
Chart 1. The point scoring ranged from 5 to 8, 
with a maximum of 10.
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Sample and Characterization of 
Sexual Dysfunctions
In the articles selected for review, there 
was a discrepancy concerning homogeneity 
and sample size, with an average of 138.5 (16 
to 245) women included. The majority was 
written in the English language, with only one 
in Portuguese. The countries with the most 
publications on the theme were the United 
States with 36.4% (n = 4), the United Kingdom 
and Norway each with 18.1% (n = 2 each), and 
one paper each (9%) from Australia, Brazil, 
and Japan (n = 1).
In the present review, Dyspareunia was 
the most common FSD, being the object of 
study in 81.8% of the subjects (n = 9), female 
orgasmic disorder in 18.2% (n = 2), and then 
female desire and/or arousal disorder and 
FSDs in general, representing 9% (n = 1) of the 
studies (Chart 2).
Physiotherapeutic Approach
The treatments proposed for FSDs were 
Kinesiotherapy (Kegel exercises and PFMT), 
Cognitive behavioral therapy (CBT), Biofeed-
back, Electrotherapy (transcutaneous elec-
trical stimulation - TENS, and therapeutic 
ultrasound - US), and Manual Therapy. All 
the studies showed improvement in sexual 
function after physiotherapeutic intervention 
(Chart 3). Kinesiotherapy was used in five of 
the studies,9,15,17,19,21 while Combined Therapy 
was employed in two others, one of which 
combined Kinesiotherapy with Biofeedback22 
and the other using Electrotherapy, Kinesio-
therapy, and Biofeedback.23 Interventions us-
ing only electrotherapeutic resources can be 
observed in two studies.18,20 Only one author 
did the intervention using Manual Therapy14 
and separately, in three groups, used CBT, Bio-
feedback, and Vestibulectomy.16
DISCUSSION
The objective of this systematic review 
was to verify the physiotherapeutic tech-
niques used in treating Female Sexual Dys-
functions (FSDs). This information is necessary 
since the prevalence of FSDs has increased in 
recent years, affecting some 67.9% of women 
worldwide.5,6
The studies included in this review dealt 
with kinesiotherapy, electrotherapy, manual 
therapy, and in some combinations. Despite 
being distinct regarding applicability, time of 
use, and the dysfunction treated, the evidence 
contained shows the effective role of physio-
therapy in treating FSDs.
Figure 1. Flowchart with the electronic search criteria on three databases
Chart 1. Evaluation of the methodological quality of the randomized clinical trials included 
using the PEDro scale
Study
Physiotherapy Evidence Database
(1)* (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) Total
Bergeron et al.16 + + - + - - - + + + + 6
Bo et al.15 - + - + - - - + - + + 5
Everett et al.20 + + + + + + + - - + + 8
Murina et al.18 + + - + + - + + + - + 7
Liebergall-Wischnitzer et al.19 + + - + - - + - - + + 5
(1): eligibility; (2): random distribution; (3): allocation concealment; (4): comparability base; (5): blinded subjects; (6): blinded therapists; (7): 
blinded evaluators; (8): adequate follow-up; (9): analysis by intention to treat; (10): comparisons between groups; (11): estimated scores and 
variability. (+): criterion is clearly satisfied; (-): criterion is not satisfied. * The item ‘eligibility criteria’ did not contribute towards overall scoring
Only one study15 did not describe its eli-
gibility criteria (16.6% of the articles). As for 
allocation concealment, 83%15-19 failed to ful-
fill this item. In 33.3% at least 16% of the par-
ticipants quit after starting the intervention. 
In the items referring to being blinded, 83% 
did not blind the therapists,15,16 while 66.6% 
used blinded evaluators16,18,19,20 and 33.3% had 
blinded individuals.18,20
The analysis by intention to treat was 
done in half the cases.15,19,20 Criteria such as 
random distribution, similarity of the most im-
portant prognostic indicators, and measures 
of accuracy and of variability of at least one 
key outcome were always respected.
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Chart 2. Characterization of the included studies
Author, year, country Magazine Type of Study Sample Age Sexual Dysfunction Study Objective
Bergeron et al.16 
2001, Canada
Pain/USA RCT 87/Vulvar Vestibulitis 26.8 Dyspareunia Compare the effects of CBT, elec-
tromyography, Biofeedback, and 
Vestibulectomy in dyspareunia
Dionisi & Senatori13 
2011, Italy
The Journal of Obstetrics and 
Gynecology Research/Japan
Cohort/ 
Prospective
45/post-partum 
perineal trauma 
32.6 (27-37) Dyspareunia Evaluate the efficacy of 
intra-vaginal TENS in the treatment 
of dyspareunia.
Zahariou et al.22 
2008, Greece
International Urogynecology 
Journal/Australia
Prospective 229/pre-menopause 
and post- menopause
43 (21-52) FSD Evaluate the efficacy of PFMT in SF 
of women with UI
Murina et al.18 
2008, Italy
International Journal of 
Obstetrics and Gynaecology/
United Kingdom
RCT 40/Vestibulodynia 30 (21-44) GE/ 
26(21-35) GP
Dyspareunia Evaluate the efficacy of TENS in 
treating vestibulodynia
Everett et al.20 
1992, United Kingdom
Physiotherapy/United Kingdom RCT 69/birth complications 27.7 GE/26.5 GP Dyspareunia Evaluate the use of therapeutic 
ultrasound in reducing dyspareunia 
and/or persistent pain.
Bo et al.15 
2000, Norway
Acta Obstetricia et Gyneco-
logica Scandinavica/(Acta 
Obstetrics and Gynecology 
Scandanavia/Norway)
RCT 59 49.6 GE/51.7 GP Dyspareunia Evaluate the efficacy of PFMT in the 
QL and SF in women with UI.
Piassarolli et al.9 
2010, Brasil
Revista Brasileira de Ginecolo-
gia e Obstetrícia/Brasil (Brazilian 
Journal of Gynecology and 
Obstetrics/Brazil)
Clinical Trial 26/Sexual Dysfunction 30.5 Orgasmic, desire, or 
arousal disorder and/or 
dyspareunia
Evaluate the effect of PFMT on FSD.
Citak et al.17 
2010, Turkey
Acta Obstetricia et Gyneco-
logica Scandinavica (Acta 
Obstetrics and Gynecology 
Scandanavia/Norway)
Prospective 118/Primiparous 
vaginal birth
23 GE/22.2 GP Dyspareunia Evaluate the effect of post-partum 
PFMT on sexual function. 
Liebergall-Wischnitzer 
et al.19 2012, Israel
Journal of Sexual Medicine/USA RCT 245/UI 46.7MP/ 
46.6 TMAP
Dyspareunia Evaluate the effectiveness of PM 
with PFMT on SF and QL in women 
with UI.
Chambless et al.21 
1984, USA
Journal of Consulting and 
Clinical Psychology/USA
Case-control 16/orgasmic disorders 27.4 (20-41) Orgasmic Disorder Examine the effects of Kegel 
exercises on orgasm.
Wurn et al.14 
2004, USA
Medscape General Medicine/
USA
Experimental 29/FSD, infertility, 
abdominal and pelvic 
adhesions 
33.8 (25-43) Dyspareunia FSD. Evaluate the efficacy of a MT 
technique on the increase of 
orgasm and the reduction of dys-
pareunia in women with a history of 
abdominal or pelvic adhesions.
USA: United States; RCT: Randomized Clinical Trial; CBT: Cognitive Behavioral Therapy; PFMT: Pelvic Floor Muscle Therapy; SG: Study Group; PG: Placebo Group; FSD: Female Sexual Dysfunction; PM Paula Method; SF: Sexual 
Function; QL: Quality of Life; UI: Urinary Incontinence; MT: Manual Therapy
Kinesiotherapy, also known as pelvic floor 
muscle training (PFMT) or Kegel exercises, is 
applicable in treating FSDs due to its recruit-
ment of local musculature and the conse-
quent pelvic vascularization and clitoral sen-
sitivity. This effect improves excitation and 
lubrication. Additionally, according to a study 
by Piassarolli et al.,9 these exercises increase 
awareness and proprioception of the muscu-
lature in the perineal region, the receptivity to 
sexual relations, and satisfaction with perfor-
mance. For Chambless et al.,21 such a practice 
for ten minutes a day was enough to strength-
en the muscles and increase the frequency of 
orgasms in the studied sample. The same was 
described in a study by Liebergall-Wischnitzer 
et al.,19 which showed a reduction in dyspa-
reunia by using this technique on women with 
urinary incontinence (UI). However, in the 
study by Bo et al.,15 with the same population, 
the results were to the contrary, showing no 
improvement in pain.
Electrotherapy has an analgesic effect. 
Using TENS,18 based on behavioral theory, 
showed positive results in treating vestibu-
lodynia that remained after three months. In 
spite of ultrasound (US) having an anti-inflam-
matory effect due to the deep heating and 
consequent vasodilation, the use of this tech-
nique on dyspareunia showed no significant 
results in the study by Everett et al.20 This fact 
occurred due to the small sample size and by 
the lack of a control group, according to those 
authors.
Manual therapy was used in the treat-
ment of adhesions stemming from gyneco-
logical complications that could have set off 
the dyspareunia and orgasmic dysfunction in 
women with FSDs.14 The diminution of pain, 
improvement in orgasm, libido, excitation, 
and lubrication were all confirmed, for it acts 
towards the relaxation of the musculature, 
better muscle recruitment, and increased lo-
cal vascularization. Such effects are necessary 
for an adequate female sexual response.3 The 
study by Bergeron et al.,16 used three different 
methods to treat vulvar vestibulitis. The inter-
ventions were surgical (vestibulectomy), CBT, 
and Biofeedback; the three treatments were 
effective, but the first was the most effective.
Therapy combined with kinesiotherapy 
and biofeedback was used on women with UI 
and FSDs.22 The most frequent problems were 
lack of libido and pain, because acidic urine af-
fects normal vaginal pH, which causes vaginal 
dryness and leads to dyspareunia. After PFMT 
there was an improvement in sexual function 
following an increase in lubrication and de-
crease in pain.
The combination of therapies was used 
to treat dyspareunia in women after normal 
childbirth.23 The intervention was based on 
electrotherapy sessions using TENS, kinesio-
therapy, and massage therapy concomitantly. 
At the final treatment, there was an esthetic 
improvement of the perineal scar, reduction 
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Chart 3. Summary of the included studies
Author, year, country Instruments Intervention Intervention of study group Intervention of control group Main Results
Bergeron et al.16 
2001, Canada
1. SF-MPQ 
2. DSFI 
3. BSI-GSI
1. CBT; 
2. Electromyographical 
biofeedback; 
3. Vestibulectomy
Biofeedback (8 sessions - 45 min - 60 
repetitions with 10” R and 10” MC)
NS 1. SF-MPQ 
CBT (PRE 5.45 > POS 5.26) 
Biofeedback (PRE 5.79 > POS 4.55) 
2. DSFI 
CBT (PRE 21.82 > POS21.75) 
Biofeedback (PRE 21.46 < POS 22.18) 
3. GSI-BSI 
CBT (PRE 56.36 > POS 52.89) 
Biofeedback (PRE 54.11 > POS 51.29)
Dionisi & Senatori13 
2011, Italy
1. EVA 
2. Marinoff 
Dyspareunia Scale 
3. Goethe scale
1. TENS 
2. PFMT 
3. Biofeedback
TENS (30min/WK, biphasic pulses, 
f:10-50 Hz and 300/100/3000µs. A: 
10-100mA) PFMT: C/R 15 min morning 
& 10 min at night) Biofeedback: 1 
session
NS 1. VAS (PRE 8 > POS 1.5) 
2. Marinoff (PRE 2 to 3 > POS 0) 
3. Goethe scale (PRE-3 to 4 > 
POS -0 to 1)
Zahariou et al.22 
2008, Greece
1. FSFI 1. PFMT 
2. Biofeedback
PFMT daily: (2x5 RSC, 10” rest - 10x) 
Biofeedback: (30 min/month
NS 1. FSFI (PRE-20.3 < POS-26.8)
Murina et al.18 
2008, Italy
1. FSFI 
2. EVA 
3. SF-MPQ 
4. Marinoff 
Dyspareunia Scale.
1. TENS TENS: (20 sessions - 2x/WK. 15’ f: 10Hz, 
50-100µs and 15’ pause)
TENS: (20 sessions - 2xWK. 
f: 2Hz and 2µs 15’ pause)
1. FSFI (PRE 16.3 < POS 25.3) 
2. VAS (PRE 6.2 > POS-2.1) 
3. SF-MPQ (PRE -19.5 > POS-8.5) 
4. Marinoff Dyspareunia Scale 
(PRE 2.7 > POS 1.1)
Everett et al.20 
1992, United Kingdom
1. Assessment of 
perineal pain
1. US US: (f: 3MHz, I = 0.5W/cm2, pulse 
interval 1:1, for 5’ 3xWK)
Placebo 1. Qualitative analysis: less perineal 
pain
Bo et al.15 
2000, Norway
1. B-FLUTS 1. PFMT PFMT: (3x8-12MC 3x/day; 45’ - 1x/WK) No intervention 1. B-FLUTS 
Pain (PRE 33.4% > POS10.5%) 
Sexual function (PRE40% > POS16.7%)
Piassarolli et al.9 
2010, Brazil
1. Bidigital vaginal 
palpation 
2. Intravaginal 
Electromyography 
3. FSFI
1. PFMT PFMT: (5C phases and 5C tonics of 
0”-R10” = 100 contractions/day)
NS FSFI (PRE-18.5 < POS-30.3); 
PFMT (PRE-1 or 2 < POS-4 or 5).
Citak et al.17 
2010, Turkey
1. Oxford Grading 
System 
2. Manometer 
3. FSFI 
4. Level of pain
1. PFMT PFMT: 1st- (C/R - 3” -10x 2” 1-x/day/15 
days) 2nd-(C/R for 5” and 15x/day)
No intervention 3. FSFI (Experimental 28.92 > Control 
-26.58).
Liebergall-Wischnitzer 
et al.19 2012, Israel
1. PISQ-12 1. PFMT 
2. PM
PM: (45’ 1x/WK) PFMT: (Groups of 10 
people, 30’, 1x/WK-4 WK)
NS 1. PISQ-12: PM (PRE -37.32 < POS 
-38.72) PFMT (PRE 37.15 < POS - 38.07)
Chambless et al.21 
1984, USA
1. SAI-E 
2. WSQ 
3. PCMS
1. Kegel Exercises Kegel Exercises (10’-2x/day) Placebo Group: (10 
non-sexual images viewed 
for 1’ - 10’ -2x/day)
1. SAI-E: NS 
2. WSQ: (PRE 1.6 < POS 2.5) 
3. PC Strength: (PRE 18.33mm < POS 
28.17mm)
Wurn et al.14 
2004, USA
1. FSFI 1. Manual Therapy Intensive sessions 2 to 4 hours/day-5x/
WK
NS 1. FSFI (PRE-19.5 < POS-29.1)
CinT: Kinesiotherapy; CBT: Cognitive Behavioral Therapy; PFMT: Pelvic Floor Muscle Training; TENS: Transcutaneous Electro-neural Stimulation; US: Ultrasound Therapy; PM: Paula Method; UI: Urinary Incontinence; A: 
Amplitude; I: Intensity; f: Frequency; C: Contraction; MC: Maximum Contraction; RSC: Rapid Sustained Contractions; R: Relaxation; WK: Week; NS: Not Specified; B-FLUTS: Bristol Female Lower Urinary Tract Symptons; GSI-BSI: 
Global Severity Index of the Brief Symptom Inventory; DSFI: Derogatis Sexual Function Inventory; VAS: Visual Analog Scale; FSFI: female sexual function index; PISQ-12: Pelvic Organ Prolapse/Urinary Incontinence Sexual 
Questionnaire; SAI-E: Sexual Arousability Inventory - Expanded Form; SF-MPQ: McGill-Melzack Pain Questionnaire; WSQ: Women’s Sexuality Questionnaire. PFMS: Pelvic Floor Muscle Strength; PCMS: Pubo-coccygeal Muscle 
Strength; PRE: Pre-intervention; POS: Post-intervention
in pelvic floor hypertonia that led to a realign-
ment of the vaginal apex, a reduction in ten-
sion, and an increase in sexual intimacy. These 
results continued eight months after the end 
of treatments.
As to methodological evaluation, it was 
difficult to blind the therapist in studies of 
physiotherapy, since there is a need to know 
the parameters and the techniques used, such 
as the alterations in frequency and intensity 
in studies that used US or TENS for the con-
trol and intervention groups. However, there 
being no mention of concealed allocation and 
the non-use of blinded evaluators and sub-
jects are factors that could introduce bias in 
the performance, for psychological factors can 
intensify or undermine the signs and symp-
toms being evaluated, depending on the ther-
apy or placebo being used.24
Another possible bias found in 50% of the 
studies was the non-fulfillment of the inten-
tion to treat, which demands that individuals 
who do not complete studies be included in 
the results. Such data can mask the equiva-
lence and adherence to the treatment.25
In light of the foregoing, it is advisable that 
studies fulfill the methodological demands of 
randomized clinical trials in order to guaran-
tee the results of the therapeutic results in 
treating FSDs.
Some limitations were found in this re-
view, such as the unavailability of some 
articles in full and their low methodological 
quality, given the lack of clarity and coherence 
in the interventions as well as in their results.
CONCLUSION
The results of this systematic review indi-
cate that physiotherapeutic treatments such 
as kinesiotherapy, electrotherapy, and man-
ual therapy, as well as in combinations, are 
effective treatments of FSDs in most cases. 
There is no consensus as to the most effective 
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intervention - however, kinesiotherapy after 
PFMT appears to be beneficial when done 
weekly at home, since it is easy to perform, in-
expensive, quick to learn, and provides lasting 
results in a short period of time.
Physiotherapy such as that for treating 
FSDs needs to be better studied and evalu-
ated, for there are still gaps in understanding 
that need to be filled. Some of the included 
studies lacked methodological rigor due to 
not having a control group, not randomizing 
the subjects, or having only a small sample. 
These aspects make it difficult to assess which 
is the best treatment for FSDs, since they can 
be used separately or in combination.
Due to the low methodological quality 
of the studies and the heterogeneity of the 
research samples, there still is no definitive 
dosage or duration of therapy with the best 
cost-benefit ratio. This makes it necessary to 
do prospective research in order to verify the 
long-term effectiveness of physiotherapy in 
the treatment of FSDs.
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